Delivery Order SPE2DB20D1100-SPE2DB25FE1DJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive delivery order, issued on March 5, 2025, with an ultimate completion date of March 26, 2025, represents a firm fixed price procurement with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin-based therapeutic product commonly used for medical and cosmetic purposes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a $26,819.52 delivery order to AmerisourceBergen Drug Corp for 200 unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. Issued on August 19, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, awarded on August 28, 2025, is set to be completed by September 19, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. As a non-set-aside competitive award, this delivery order was issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,039.40 to AmerisourceBergen Drug Corp for 50-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used in medical and therapeutic applications. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 7, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $33,524.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin injection used primarily for treating muscle spasticity and dystonia in military and veteran healthcare populations. This non-set-aside contract, awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,514.33 for 100-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic applications. This firm fixed price contract, awarded on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract was competitively awarded with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.44 to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competed award under the company's existing contract vehicle with the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $27,937 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic purposes. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a non-competitive, direct fulfillment order under AmerisourceBergen's existing Indefinite Delivery Contract vehicle. The place of performance is AmerisourceBergen's corporate office...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1DJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes, valued at $42,642.60. This firm fixed-price delivery order, awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains a substantial $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026, which enables the supply of a comprehensive range of pharmaceuticals, specialty medications, vaccines, and medical supplies to support military healthcare programs globally. This delivery order for XEOMIN reflects AmerisourceBergen's ongoing role in supplying specialized pharmaceutical products to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.6k | 9/25/25 |